Call for guidelines for monitoring renal function and haematological variables during intravenous infusion of immunoglobulin in neurological patients [7]

Journal of Neurology Neurosurgery and Psychiatry

Volumn 71, Issue 4, 2001, Pages 562-563

  Bajaj, N P S ^a   Henderson, N ^a   Bahl, R ^a   Stott, K ^a   Clifford Jones, R E ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; IMMUNOGLOBULIN; OCTOGAM; UREA; VIGAM;

ADULT; AGED; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL ARTICLE; DOSE KIDNEY FUNCTION RELATION; DRUG SAFETY; FEVER; GUILLAIN BARRE SYNDROME; HEADACHE; HUMAN; IMMUNOTHERAPY; LETTER; LEUKOPENIA; MOTOR NEUROPATHY; MYASTHENIA GRAVIS; NAUSEA; NEUTROPENIA; PATIENT MONITORING; PRIORITY JOURNAL; RASH; TACHYCARDIA; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; BLOOD CHEMICAL ANALYSIS; DEMYELINATING AUTOIMMUNE DISEASES, CNS; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS, INTRAVENOUS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PRACTICE GUIDELINES; RETROSPECTIVE STUDIES;

EID: 0034807342     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.71.4.562     Document Type: Letter

References (5)

1. Complications of intravenous immune globulin treatment in neurologic disease
2. Mechanism of action of intravenous immunoglobulin and therapeutic considerations in the treatment of autoimmune neurologic diseases
3. Effect of high-dose intravenous immunoglobulin on serum chemistry, haematology, and lymphocyte subpopulations: Assessments based on controlled treatment trials in patients with neurologic diseases
4. Acute renal failure after large doses of intravenous immunoglobulin
5. Nephrotoxicity of intravenous immunoglobulin